U.S. STEM CELL, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-09-01: Reporting owner Knutson Gregory; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2017-08-07: Reporting owner Comella Kristin C; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-07: Reporting owner Comella Kristin C; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-07: Reporting owner TOMAS MIKE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-09-01 holding as of filing | Knutson Gregory Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.03 exercise price | 2017-09-01 | ||
| 2017-08-07 | Comella Kristin C Director, Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500,000 19,197,746 owned after | $0.03 exercise price | 2017-09-01 | |
| 2017-08-07 | Comella Kristin C Director, Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 20,697,746 owned after | $0.03 exercise price | 2017-09-01 | |
| 2017-08-07 | TOMAS MIKE Director, Officer (CEO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000,000 36,841,284 owned after | $0.03 exercise price | 2017-09-01 | |
| 2017-08-07 | TOMAS MIKE Director, Officer (CEO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 38,341,284 owned after | $0.03 exercise price | 2017-09-01 | |
| 2017-08-07 | MURPHY WILLIAM P JR Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 3,003,087 owned after | $0.03 exercise price | 2017-08-25 | |
| 2017-08-07 | Borman Mark P Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 3,002,810 owned after | $0.03 exercise price | 2017-08-25 | |
| 2017-08-07 | Anderson Sheldon T. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 3,001,400 owned after | $0.03 exercise price | 2017-08-25 | |
| 2017-02-06 | TOMAS MIKE Director, Officer (CEO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000,000 21,841,284 owned after | $0.00 | 2017-02-17 | |
| 2017-02-06 | Comella Kristin C Director, Officer (Chief Scientific Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000,000 11,697,748 owned after | $0.00 | 2017-02-17 |